Xenon Pharmaceuticals
XENE
$43.54
Share price
1.24%
Change (1 day)
8.35%
Change (1 year)
Categories
Xenon Pharmaceuticals (XENE) Fails to deliver data
Key failure to deliver metrics for Xenon Pharmaceuticals:
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0.08 M
- Last 3 months FTD volume: $0.44 M
- Last year FTD volume: $4.26 M
Failures to deliver for Xenon Pharmaceuticals (XENE) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Xenon Pharmaceuticals (XENE) - since 2014
Volume in USD (price x number of shares), data since 2014Xenon Pharmaceuticals (XENE) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.5 M | -89.88% |
| 2023 | $4.99 M | -70.64% |
| 2022 | $17.02 M | -27.52% |
| 2021 | $23.49 M | 628.07% |
| 2020 | $3.22 M | -70.3% |
| 2019 | $10.86 M | 62.02% |
| 2018 | $6.7 M | 798.04% |
| 2017 | $0.74 M | -31.34% |
| 2016 | $1.08 M | -12.33% |
| 2015 | $1.24 M | 130.12% |
| 2014 | $0.53 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Coherus BioSciences
CHRS | $2.28 M | $16.53 M | 🇺🇸 USA |
 Atara Biotherapeutics ATRA | $1.46 M | $3.18 M | 🇺🇸 USA |